These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18425914)

  • 21. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll R; Wiswell TE
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006180. PubMed ID: 19821357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventions for non-oliguric hyperkalaemia in preterm neonates.
    Vemgal P; Ohlsson A
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005257. PubMed ID: 17253550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant for meconium aspiration syndrome in term and late preterm infants.
    El Shahed AI; Dargaville PA; Ohlsson A; Soll R
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD002054. PubMed ID: 25504256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human activated protein C for severe sepsis in neonates.
    Kylat RI; Ohlsson A
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005385. PubMed ID: 16625638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD001079. PubMed ID: 20091513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
    Lemyre B; Davis PG; De Paoli AG; Kirpalani H
    Cochrane Database Syst Rev; 2014 Sep; (9):CD003212. PubMed ID: 25188554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Ardell S; Pfister RH; Soll R
    Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early introduction of lipids to parenterally-fed preterm infants.
    Simmer K; Rao SC
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005256. PubMed ID: 15846747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2011 Jul; (7):CD004213. PubMed ID: 21735396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic surfactant for respiratory distress syndrome in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; 1998(2):CD001149. PubMed ID: 10796417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cromolyn sodium for the prevention of chronic lung disease in preterm infants.
    Ng GY; Ohlsson A
    Cochrane Database Syst Rev; 2001; (2):CD003059. PubMed ID: 11406065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia.
    Mohan P; Brocklehurst P
    Cochrane Database Syst Rev; 2003; (4):CD003956. PubMed ID: 14584000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants.
    Henderson-Smart DJ; Bhuta T; Cools F; Offringa M
    Cochrane Database Syst Rev; 2000; (2):CD000104. PubMed ID: 10796129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.
    Ng GY; da S; Ohlsson A
    Cochrane Database Syst Rev; 2001; (3):CD003214. PubMed ID: 11687053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elective high-frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants.
    Neonatology; 2013; 103(1):7-8; discussion 8-9. PubMed ID: 23037971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.